Controlled substances (g) in Maine as reported to the Drug Enforcement Administration’s Automation of Reports and Consolidated Ordering System
| 2007 | 2012 (% of 2007) | 2017 (% of 2012) | |
| Opioids | |||
| Oxycodone (II)1.5 | 309 762 | 384 475 (+24.1) | 204 308 (−46.8) |
| Methadone (II)10 | 164 090 | 167 642 (+2.2) | 126 225 (−24.7) |
| Morphine (II)1 | 119 823 | 117 676 (−1.8) | 65 934 (−44.0) |
| Hydrocodone (II)1 | 113 910 | 155 652 (+36.6) | 68 460 (−56.0) |
| Codeine (II)1 | 72 375 | 63 062 (−12.9) | 41 556 (−34.1) |
| Buprenorphine (III)10 | 11 343 | 24 481 (+115.8) | 38 720 (+58.1) |
| Meperidine (II)0.1 | 9888 | 5506 (−44.3) | 1578 (−71.3) |
| Hydromorphone (II)4 | 5196 | 7946 (+52.9) | 6686 (−15.8) |
| Fentanyl base (II)75 | 2053 | 2612 (+27.2) | 1323 (−49.4) |
| Oxymorphone (II)3 | 1101 | 4781 (+334.4) | 3699 (−22.6) |
| Opium powdered (II)1 | 184 | 211 (+14.5) | 199 (−5.6) |
| Tapentadol (II)0.4 | NA | 112 412 (NA) | 5636 (−49.9) |
| Stimulants | |||
| Methylphenidate (II) | 125 473 | 157 025 (+25.1) | 141 225 (−10.1) |
| Amphetamine (II) | 49 039 | 69 807 (+42.4) | 90 672 (+29.9) |
| Lisdexamfetamine (II) | 2469 | 57 836 (+22420.1) | 67 311 (+16.4) |
| Cocaine (II) | 271 | 147 (−46.0) | 87 (−40.3) |
| Barbiturates | |||
| Pentobarbital (II) | 83 213 | 69 998 (−15.9) | 80 881 (+15.5) |
| Butalbital (III) | 8435 | 7590 (−10.0) | 2520 (−66.8) |
| Population (millions) | 1.327 | 1.328 (+0.1) | 1.336 (+0.7) |
US Controlled Substance Act schedule is in parentheses; Morphine mg equivalent of opioids is in superscripts. Maine population is from the US Census.
NA, not applicable (approved in 2008).